These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 709781

  • 1. Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
    Mason JW, Winkle RA.
    Circulation; 1978 Dec; 58(6):971-85. PubMed ID: 709781
    [Abstract] [Full Text] [Related]

  • 2. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN, Josephson ME, Farshidi A, Spielman SR, Michelson EL, Greenspan AM.
    Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
    [Abstract] [Full Text] [Related]

  • 3. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
    Waxman HL, Buxton AE, Sadowski LM, Josephson ME.
    Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803
    [Abstract] [Full Text] [Related]

  • 4. Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia.
    Griffith MJ, Linker NJ, Garratt CJ, Ward DE, Camm AJ.
    Lancet; 1990 Sep 15; 336(8716):670-3. PubMed ID: 1975861
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of recurrent symptomatic ventricular tachycardia.
    Winkle RA, Alderman EL, Fitzgerald JW, Harrison DC.
    Ann Intern Med; 1976 Jul 15; 85(1):1-7. PubMed ID: 937905
    [Abstract] [Full Text] [Related]

  • 10. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
    Ross DL, Sze DY, Keefe DL, Swerdlow CD, Echt DS, Griffin JC, Winkle RA, Mason JW.
    Circulation; 1982 Dec 15; 66(6):1205-10. PubMed ID: 6814784
    [Abstract] [Full Text] [Related]

  • 11. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
    Meltzer RS, Robert EW, McMorrow M, Martin RP.
    Am J Cardiol; 1978 Dec 15; 42(6):1049-53. PubMed ID: 727132
    [Abstract] [Full Text] [Related]

  • 12. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG, Martins JB, Wendt DJ, Constantin L, Hopson R, McCue ML.
    Am J Cardiol; 1988 May 01; 61(13):1012-7. PubMed ID: 3129926
    [Abstract] [Full Text] [Related]

  • 13. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
    Whitford EG, McGovern B, Schoenfeld MH, Garan H, Newell JB, McElroy M, Ruskin JN.
    Am Heart J; 1988 Feb 01; 115(2):360-6. PubMed ID: 3341170
    [Abstract] [Full Text] [Related]

  • 14. Intracardiac electrophysiologic studies as a method for the optimization of drug therapy in chronic ventricular arrhythmia.
    Horowitz LN, Josephson ME, Kastor JA.
    Prog Cardiovasc Dis; 1980 Feb 01; 23(2):81-98. PubMed ID: 6997925
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness of propranolol added to a type I antiarrhythmic agent for sustained ventricular tachycardia secondary to coronary artery disease.
    Friehling TD, Lipshutz H, Marinchak RA, Stohler JL, Kowey PR.
    Am J Cardiol; 1990 Jun 01; 65(20):1328-33. PubMed ID: 2343820
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ventricular tachycardia.
    Willerson JT, Yurchak PM, DeSanctis RW.
    Cardiovasc Clin; 1970 Jun 01; 2(2):69-86. PubMed ID: 4131129
    [No Abstract] [Full Text] [Related]

  • 20. Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia.
    Dorian P, Newman D, Berman N, Hardy J, Mitchell J.
    J Am Coll Cardiol; 1993 Jul 01; 22(1):106-13. PubMed ID: 8509529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.